Arm or belly? study seeks best spot for blood clot shot in severe obesity
NCT ID NCT07213713
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether injecting the blood thinner enoxaparin into the arm or the abdomen works better for preventing blood clots in people with severe obesity (BMI over 40). Researchers will measure drug levels in the blood to see which injection site gives the right amount. The study plans to enroll 80 adults who need clot prevention.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- enoxaparin
- What this could lead to
- If successful, this could show the best injection site for enoxaparin in people with severe obesity, improving clot prevention.
- What could go wrong
- This is a small, early-stage study (80 people) that only measures drug levels, not actual clot prevention. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESE PATIENTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Will shedding pounds heal the pancreas? MRI scans seek answers
- Can a second bypass surgery rescue failed weight loss?
- Could tailored blood thinner dosing prevent strokes in chinese patients?
- Could a simple aspirin pill replace daily shots to prevent postpartum blood clots?
- Simple 5-Step nursing plan could slash deadly clot risk after hip surgery
- MRI reveals how weight loss drugs reshape organs in severely obese teens